In a mouse model of melanoma, ginsenoside Rh2 induced a large number of CD4+ and CD8a+T lymphocytes to infiltrate into the tumor tissue, indicating an enhanced immune response and enhanced cytotoxicity of lymphocytes to melanoma cells B16-F10 (73). Here, CD4 is linked to melanoma.